20/20 Focus On Research Seminar Series with Tarjani Shukla
“A highly selective MNK1/MNK2 inhibitor rescues core deficits associated with Fragile X Syndrome” by Tarjani Shukla, a Ph.D. candidate in Molecular and Cell Biology at the University of Texas at Dallas. Abstract: The behavioral deficits associated with Fragile X syndrome…